Allahabad HC rejects bail pleas of two accused in Phensedyl syrup case

Lucknow:  The Allahabad High Court on Wednesday rejected the bail pleas of two accused in an alleged illegal stocking and transportation of Phensedyl cough syrup case.

Justice Karunesh Singh Pawar of the Lucknow bench passed the order on separate bail applications filed by the two accused Vibhor Rana and Vishal Singh.

The court had earlier granted them interim bail on December 18. Following the rejection of their regular bail pleas, both accused will have to surrender.

Opposing the bail applications, Additional Advocate General Anoop Trivedi submitted that information had been received over several days that Phensedyl cough syrup and other drugs were being illegally stored for intoxicating purposes and transported to Bihar, Jharkhand, West Bengal, Assam and Bangladesh.

He told the court that on February 12, 2024, the Uttar Pradesh government constituted a joint team of the Special Task Force and the Food Safety and Drug Administration to probe the matter.

On April 8, 2024, the STF received specific inputs that a truck loaded with cough syrup was being transported from Transport Nagar in Lucknow to Cooch Behar in West Bengal.

The STF intercepted the truck on Sultanpur Road and seized 52 cartons of cough syrup. During questioning, the truck driver, Dharmendra Kumar, allegedly disclosed the involvement of Rana and Singh in the case.

Subsequently, the STF arrested Rana and his associates from Saharanpur on November 11, 2025, the AAG said, adding that there was ample evidence against the accused and they were not entitled to bail.

Authorities in Uttar Pradesh are also carrying out a wider probe into the alleged illegal stocking and trade of regulated codeine-based syrups within and outside the state, with officials estimating that the racket runs into hundreds of crores of rupees.

Related Posts

NHS backs delayed‑release treatment for cystinosis

Decision expands options for eligible patients NHS England has recommended delayed‑release mercaptamine bitartrate for routine commissioning for eligible patients aged one year and above with nephropathic cystinosis. The decision provides…

Maharashtra FDA Permanently Cancels Licence of Pune Ayurvedic Drug Manufacturer Over Serious GMP and Quality Violations

Mumbai/Pune: In a major regulatory enforcement action aimed at safeguarding public health, the Maharashtra Food and Drug Administration (FDA) has permanently cancelled the Ayurvedic drug manufacturing licence of Pune-based M/s Inducare Pharma…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

NHS backs delayed‑release treatment for cystinosis

NHS backs delayed‑release treatment for cystinosis

Promotion of Drug Inspectors (Medical Devices) raises hopes of Effective Regulation & Patient Safety

Promotion of Drug Inspectors (Medical Devices) raises hopes of Effective Regulation & Patient Safety

Maharashtra FDA Permanently Cancels Licence of Pune Ayurvedic Drug Manufacturer Over Serious GMP and Quality Violations

Maharashtra FDA Permanently Cancels Licence of Pune Ayurvedic Drug Manufacturer Over Serious GMP and Quality Violations

Telangana DCA Seizes Gabapentin Tablets Falsely Sold as Nutraceuticals in Hyderabad

Telangana DCA Seizes Gabapentin Tablets Falsely Sold as Nutraceuticals in Hyderabad

Massive Blood Wastage in Gujarat: Over 85,000 Units Discarded Due to Storage Lapses and Expiry

Massive Blood Wastage in Gujarat: Over 85,000 Units Discarded Due to Storage Lapses and Expiry

AmeriHealth Home Healthcare Celebrates 5 Years of Compassionate Care

AmeriHealth Home Healthcare Celebrates 5 Years of Compassionate Care